Quick Answer
DNA X, Inc. reported Gross Profit of $9.92 million for fiscal year 2024.
DNA X, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2024 | $9.92M | -48.7% |
| 2023 | $19.32M | +66.3% |
| 2022 | $11.62M | +81.2% |
| 2021 | $6.41M | -57.8% |
| 2020 | $15.21M | -55.9% |
| 2019 | $34.51M | -28.2% |
| 2018 | $48.09M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.82M | -57.1% | +114.9% |
| June 30, 2025 | $845.0K | -71.5% | -89.9% |
| March 31, 2025 | $8.36M | +187.9% | +97.4% |
| September 30, 2024 | $4.23M | -24.5% | +42.5% |
| June 30, 2024 | $2.97M | -32.9% | +2.3% |
| March 31, 2024 | $2.90M | -30.5% | -48.2% |
| September 30, 2023 | $5.60M | +69.0% | +26.6% |
| June 30, 2023 | $4.43M | +55.5% | +6.0% |
- DNA X, Inc. showed a decrease of -48.7% in Gross Profit compared to the prior fiscal year.
- Over the 2018–2024 period, DNA X, Inc.’s gross profit has declined by 79.4% (from $48.09 million to $9.92 million).
- The most recent figure is from DNA X, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: